"Rheumatoid Factor" - Books

Result Filters

Results: 1 to 20 of 755 books (2710 items)

<< First< Prev

Page of 38

Next >Last >>

Select item 44036681.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Top results in this book Table of Contents

Select item 26591822.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Top results in this book Table of Contents

Select item 44650643.

Autoimmunity: From Bench to Bedside [Internet].

Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors.

Bogota (Colombia): El Rosario University Press; 2013 Jul 18.

Top results in this book Table of Contents

Select item 34012944.

Endotext [Internet].

Feingold KR, Anawalt B, Blackman MR, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

Top results in this book Table of Contents

Select item 14152805.

Madame Curie Bioscience Database [Internet].

Austin (TX): Landes Bioscience; 2000-2013.

Top results in this book Table of Contents

Select item 48538166.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

Top results in this book Table of Contents

Select item 53827727.

Skills in Rheumatology [Internet].

Almoallim H, Cheikh M, editors.

Singapore: Springer; 2021.

Top results in this book Table of Contents

Select item 46030288.

Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update [Internet].

Donahue KE, Gartlehner G, Schulman ER, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul. (Comparative Effectiveness Review, No. 211.)

Top results in this book Table of Contents

Select item 29677449.

Adalimumab, Etanercept, Infliximab, Rituximab and Abatacept for the Treatment of Rheumatoid Arthritis After the Failure of a Tumour Necrosis Factor Inhibitor: A Systematic Review and Economic Evaluation.

Malottki K, Barton P, Tsourapas A, et al.

Southampton (UK): NIHR Journals Library; 2011 Mar. (Health Technology Assessment, No. 15.14.)

Top results in this book Table of Contents

Select item 425156010.

Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.

Stevenson M, Archer R, Tosh J, et al.

Southampton (UK): NIHR Journals Library; 2016 Apr. (Health Technology Assessment, No. 20.35.)

Top results in this book Table of Contents

Select item 166869011.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

Top results in this book Table of Contents

Select item 330659012.

Tocilizumab (Actemra, Intravenous): For the Treatment of Signs and Symptoms of Active Polyarticular Juvenile Idiopathic Arthritis in Patients Two Years of Age and Older Who Have Responded Inadequately to Previous Therapy With Disease-Modifying Antirheumatic Drugs and Systemic Corticosteroids [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Aug.

Top results in this book Table of Contents

Select item 532506813.

Enhancing NIH Research on Autoimmune Disease.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee for the Assessment of NIH Research on Autoimmune Diseases.

Washington (DC): National Academies Press (US); 2022 Jun 2.

Top results in this book Table of Contents

Select item 422113414.

Tocilizumab (Actemra): Adult Patients with Moderately to Severely Active Rheumatoid Arthritis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug.

Top results in this book Table of Contents

Select item 145898415.

GeneReviews® [Internet].

Adam MP, Feldman J, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2024.

Top results in this book Table of Contents

Select item 514559016.

Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation.

Tikhonova IA, Yang H, Bello S, et al.

Southampton (UK): NIHR Journals Library; 2021 Feb. (Health Technology Assessment, No. 25.8.)

Top results in this book Table of Contents

Select item 421769217.

Golimumab (Simponi) IV: In Combination with Methotrexate (MTX) for the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jul.

Top results in this book Table of Contents

Select item 466971018.

Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.

Archer R, Hock E, Hamilton J, et al.

Southampton (UK): NIHR Journals Library; 2018 Nov. (Health Technology Assessment, No. 22.66.)

Top results in this book Table of Contents

Select item 568919619.

Bimekizumab (Bimzelx): Therapeutic area: Psoriatic arthritis: CADTH Reimbursement Review [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Sep.

Top results in this book Table of Contents

Select item 452862820.

What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis.

Simpson E, Hock E, Stevenson M, et al.

Southampton (UK): NIHR Journals Library; 2018 Apr. (Health Technology Assessment, No. 22.20.)

Top results in this book Table of Contents

<< First< Prev

Page of 38

Next >Last >>

Supplemental Content

Images search in Bookshelf

Figure 6Influence of age at onset in adult Sjögren’s syndrome subphenotype.

ANA: anti-nuclear antibodies; HA: hyaluronic acid; IL-6: interleukin 6; KCS: keratoconjunctivitis sicca; RF: rheumatoid factor.

Sjögren’s syndrome.

Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors. Autoimmunity: From Bench to Bedside [Internet]. Bogota (Colombia): El Rosario University Press; 2013 Jul 18.
Figure 1Analytic framework for antibody testing for MSK complaints in pediatric populations (≤18 years)

ANA = antinuclear antibody; CCP = cyclic-citrullinated peptide; JIA = juvenile idiopathic arthritis; MSK = musculoskeletal; SLE = systemic lupus erythematosus; RF = rheumatoid factor

Introduction.

Wong KO, Bond K, Homik J, et al. Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar.
Figure 3Methodological quality of studies evaluating ANA, RF, and CCP tests for pSLE and JIA in children with undiagnosed MSK pain

ANA = antinuclear antibody test; CCP = cyclic-citrullinated peptide; JIA = juvenile idiopathic arthritis; MSK = musculoskeletal; pSLE = pediatric systemic lupus erythematosus; RF = rheumatoid factor

Results: Part Two.

Wong KO, Bond K, Homik J, et al. Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar.
Figure 6Sensitivity and specificity of an RF (IgM) test for JIA in children with undiagnosed MSK pain

FN = false negative; FP = false positive; IgM = immunoglobulin M; JIA = juvenile idiopathic arthritis; MSK = musculoskeletal; NRG = nonrheumatic disease group; ORG = other rheumatic diseases group; RF = rheumatoid factor; TN = true negative; TP = true positive.

Results: Part Two.

Wong KO, Bond K, Homik J, et al. Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar.